Cargando…
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938255/ https://www.ncbi.nlm.nih.gov/pubmed/36717677 http://dx.doi.org/10.1038/s41416-023-02159-4 |
| _version_ | 1784890590801952768 |
|---|---|
| author | Wu, Huai-liang Luo, Zi-yin He, Zong-lin Gong, Yue Mo, Miao Ming, Wai-kit Liu, Guang-yu |
| author_facet | Wu, Huai-liang Luo, Zi-yin He, Zong-lin Gong, Yue Mo, Miao Ming, Wai-kit Liu, Guang-yu |
| author_sort | Wu, Huai-liang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9938255 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99382552023-02-19 Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits Wu, Huai-liang Luo, Zi-yin He, Zong-lin Gong, Yue Mo, Miao Ming, Wai-kit Liu, Guang-yu Br J Cancer Correction Nature Publishing Group UK 2023-01-30 2023-02-16 /pmc/articles/PMC9938255/ /pubmed/36717677 http://dx.doi.org/10.1038/s41416-023-02159-4 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Wu, Huai-liang Luo, Zi-yin He, Zong-lin Gong, Yue Mo, Miao Ming, Wai-kit Liu, Guang-yu Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title | Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title_full | Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title_fullStr | Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title_full_unstemmed | Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title_short | Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits |
| title_sort | correction to: all her2-negative breast cancer patients need gbrca testing: cost-effectiveness and clinical benefits |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938255/ https://www.ncbi.nlm.nih.gov/pubmed/36717677 http://dx.doi.org/10.1038/s41416-023-02159-4 |
| work_keys_str_mv | AT wuhuailiang correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT luoziyin correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT hezonglin correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT gongyue correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT momiao correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT mingwaikit correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits AT liuguangyu correctiontoallher2negativebreastcancerpatientsneedgbrcatestingcosteffectivenessandclinicalbenefits |